— OPINION —
By Steven Grossman
Secretary Kennedy’s announcement came last Thursday: FDA’s contribution to the pending HHS reduction in force (RIF) would be 3,500 employees. That is not quite 20 percent of the agency’s total workforce. The RIF would be in addition to an unknown number of FDA employees
Continue Reading New priorities require resources, expertise, and regulations: Where will they come from?